久久久国产一区二区_欧美在线小视频_高清一区二区三区_久久综合久久久_成人久久久久久久久_亚洲精品视

加拿大Medtronic CryoCath Technologies Inc., (蒙特利爾，Montreal)   
美敦力3.8億美元收購CryoCath強化房顫領(lǐng)域 CryoCath公司主要生產(chǎn)房顫等心血管疾病冷凍消融治療法所用的冷凍系統(tǒng)。房顫是一種較常見的心率失常。房顫的治療是心率疾病治療市場中增長最迅速的部分。目前，該領(lǐng)域的領(lǐng)先者是美敦力的競爭對手St.Jude醫(yī)療器械公司
CryoCath is a medical technology company that leads the world in creating catheter- and probe-based CryoTherapy products to treat cardiovascular disease. Traditionally, the use of freezing temperatures to treat diseased tissue has been limited by the inability to deliver the treatment in a minimally invasive manner. We have successfully overcome this obstacle by developing flexible, steerable, minimally invasive catheters to deliver cold therapy safely and effectively.

Our CryoTherapy Revolution
CryoCath has blazed a trail in CryoTherapy and continues to do so with the successful U.S. launch of Freezor?, a cryocatheter for the treatment of AVNRT. To get a better idea of where we've come from and where we're going, take a look at other important company milestones.

A Culture of Leadership, Integrity and Respect
We believe that the only way for us to maintain our leadership is through empowerment, inspiration, teamwork and conviction. And as important as our R&D and commercial successes are, we are also driven by our ability to improve peoples lives profoundly through our clinical innovations.